We are live on ! Find out more
CVAC

CureVac
CVAC

Delisted

CVAC was delisted on the 5th of January, 2026.

Back to rankings

111 hedge funds and large institutions have $283M invested in CureVac in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 25 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 25

42% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 19

7% more funds holding

Funds holding: 104 → 111 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.19% less ownership

Funds ownership: 7.92% → 7.73% (-0.19%)

11% less call options, than puts

Call options by funds: $15M | Put options by funds: $16.9M

44% less capital invested

Capital invested by funds: $508M → $283M (-$225M)

Holders
111
Holders Change
+7
Holders Change %
+6.73%
% of All Funds
0%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0%
New
27
Increased
50
Reduced
25
Closed
19
Calls
$15M
Puts
$16.9M
Net Calls
-$1.86M
Net Calls Change
+$20.9M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$7.09M
2
Citadel Advisors
Citadel Advisors
Florida
+$5.58M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.75M
4
Marshall Wace
Marshall Wace
United Kingdom
+$3.43M
5
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
+$2.65M

Top Sellers

Rank Fund Capital Flow
1
GF
Gates Foundation
Washington
-$28.5M
2
SG Americas Securities
SG Americas Securities
New York
-$4.33M
3
California Public Employees Retirement System
California Public Employees Retirement System
California
-$4.14M
4
DZ Bank
DZ Bank
Germany
-$3.43M
5
EP
Eversept Partners
New York
-$2.92M

CVAC Hedge Fund Activity: Q1 2022 in Review

111 institutional investors reported a position in CureVac (CVAC) for Q1 2022, worth a combined $283M — down 44% from $508M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new CVAC positions and 19 closed out — a net gain of 8 holders — while 50 added to existing stakes and 25 trimmed.

The largest buyer was Millennium Management, adding an estimated $7.09M. The largest seller was Gates Foundation, cutting an estimated $28.5M.

  • 111 institutional investors held CureVac (CVAC) as of Q1 2022, up from 104 in Q4 2021.
  • Funds reported $283M of CureVac stock for Q1 2022, down 44% quarter-over-quarter.
  • 27 funds opened new CureVac positions in Q1 2022 and 19 closed out, a net change of +8 holders.
  • The largest CureVac buyer in Q1 2022 was Millennium Management, an estimated $7.09M added.
  • The largest CureVac seller in Q1 2022 was Gates Foundation, an estimated $28.5M sold.

Based on aggregated 13F filings for Q1 2022.